Mengmeng Zhao Selected Research

2',5'-Oligoadenylate Synthetase (2',5' Oligoadenylate Synthetase)

3/2019	Molecular cloning and functional characterization of porcine 2',5'-oligoadenylate synthetase 1b and its effect on infection with porcine reproductive and respiratory syndrome virus.
12/2018	Molecular cloning of porcine 2',5'-oligoadenylate synthetase-like protein and its role in porcine reproductive and respiratory syndrome virus infection.
9/2018	Molecular Cloning and Identification of the 2'-5' Oligoadenylate Synthetase 2 Gene in Chinese Domestic Pigs Through Bioinformatics Analysis, and Determination of Its Antiviral Activity Against Porcine Reproductive and Respiratory Syndrome Virus Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mengmeng Zhao Research Topics

Disease

12	Inflammation (Inflammations) 01/2022 - 12/2015
11	Infections 05/2022 - 04/2015
10	Neoplasms (Cancer) 05/2022 - 04/2015
5	Hearing Loss (Hearing Impairment) 01/2022 - 01/2017
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 08/2020
4	Fibrosis (Cirrhosis) 01/2022 - 01/2021
3	Critical Illness (Critically Ill) 02/2022 - 01/2021
3	Hypertension (High Blood Pressure) 01/2022 - 01/2020
3	Sepsis (Septicemia) 07/2021 - 09/2020
3	Cardiotoxicity 01/2021 - 08/2020
3	Body Weight (Weight, Body) 01/2021 - 01/2020
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 05/2022 - 05/2022
2	Cardiomegaly (Heart Hypertrophy) 01/2022 - 10/2021
2	Lung Neoplasms (Lung Cancer) 01/2022 - 07/2014
2	Atherosclerosis 01/2022 - 01/2021
2	Cardiomyopathies (Cardiomyopathy) 01/2022 - 12/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2022
2	Aortic Dissection 01/2022 - 11/2020
2	Myocardial Infarction 12/2021 - 01/2021
2	Adenocarcinoma of Lung 11/2021 - 05/2019
2	Granuloma 10/2021 - 01/2019
2	COVID-19 01/2021 - 01/2021
2	Obesity 01/2021 - 06/2020
2	Wounds and Injuries (Trauma) 09/2020 - 01/2016
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 01/2017
2	Virus Diseases (Viral Diseases) 01/2018 - 01/2017
2	Pathologic Neovascularization 01/2017 - 12/2015
2	Cleft Lip (Harelip) 07/2014 - 01/2014
1	Cystitis 11/2022
1	Pain (Aches) 11/2022
1	Neurogenic Inflammation 11/2022
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 11/2022
1	Chronic Pain 11/2022
1	Hyperalgesia 11/2022
1	Edema (Dropsy) 11/2022
1	Fatigue 06/2022
1	Communicable Diseases (Infectious Diseases) 05/2022
1	Spondylolysis 05/2022
1	Erectile Dysfunction 03/2022
1	Adenocarcinoma 01/2022
1	Genomic Instability 01/2022
1	Bites and Stings (Sting) 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2018
8	CytokinesIBA 01/2022 - 08/2014
6	Antiviral Agents (Antivirals)IBA 01/2022 - 10/2017
6	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 04/2015
4	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022 - 08/2020
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 08/2021
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2020
3	interleukin 20 (IL-20)IBA 12/2021 - 11/2020
3	LipopolysaccharidesIBA 07/2021 - 01/2020
3	LipidsIBA 07/2021 - 09/2020
3	InterleukinsIBA 05/2021 - 12/2015
3	2',5'-Oligoadenylate Synthetase (2',5' Oligoadenylate Synthetase)IBA 03/2019 - 09/2018
2	Messenger RNA (mRNA)IBA 11/2022 - 01/2022
2	VaccinesIBA 05/2022 - 01/2018
2	InterferonsIBA 01/2022 - 10/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2017
2	Citrate (si)-Synthase (Synthase, Citrate)IBA 01/2022 - 01/2017
2	Poly I-CIBA 01/2022 - 09/2018
2	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2022 - 10/2021
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 10/2020
2	resolvin D1IBA 01/2021 - 09/2020
2	5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA 10/2020 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 04/2020 - 01/2017
2	Biological ProductsIBA 12/2019 - 04/2015
2	RNA (Ribonucleic Acid)IBA 12/2019 - 05/2019
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2014 - 09/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022
1	CIM0216IBA 11/2022
1	Primidone (Sertan)FDA LinkGeneric 11/2022
1	Transient Receptor Potential ChannelsIBA 11/2022
1	Calcitonin Gene-Related PeptideIBA 11/2022
1	PregnenoloneIBA 11/2022
1	polyacrylamideIBA 06/2022
1	HydrogelsIBA 06/2022
1	Inactivated VaccinesIBA 05/2022
1	Tripartite Motif ProteinsIBA 05/2022
1	Attenuated VaccinesIBA 05/2022
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 05/2022
1	CholesterolIBA 05/2022
1	EnzymesIBA 05/2022
1	Pharmaceutical PreparationsIBA 05/2022
1	ElementsIBA 05/2022
1	avanafilIBA 03/2022
1	Phosphodiesterase 5 InhibitorsIBA 03/2022
1	AntigensIBA 02/2022
1	Ferritins (Ferritin)IBA 02/2022
1	Amino Acids FDA Link 01/2022
1	LuteinIBA 01/2022
1	Eukaryotic Translation Initiation Factor 5AIBA 01/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022
1	MicellesIBA 01/2022

Therapy/Procedure

2	Immunotherapy 02/2022 - 04/2015
2	Therapeutics 01/2022 - 01/2021
2	Artificial Respiration (Mechanical Ventilation) 01/2021 - 01/2021
1	Pedicle Screws 05/2022
1	Pneumonectomy (Lung Volume Reduction) 01/2022
1	Adjuvant Chemotherapy 01/2022